iTonic Holdings Ltd filings document foreign-issuer current reports on its brachytherapy healthcare-solutions business, corporate events and listed-company status. The company's Form 6-K disclosures include press-release exhibits, Nasdaq minimum bid price compliance matters, and descriptions of its operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., and lead treatment-planning product.
The filing record also covers material-event disclosures, material agreements, capital-structure matters, governance topics, and operating and financial results. These disclosures connect the company's public reporting to its Class A ordinary shares, healthcare-technology operations and corporate obligations as a listed issuer.
iTonic Holdings Ltd (ITOC) said shareholders approved a 16-for-1 consolidation of its Class A and Class B ordinary shares. It is scheduled to take effect at 12:01 a.m. Eastern Time on October 6, 2026, subject to completion of applicable corporate requirements and Nasdaq not objecting. Issued and outstanding Class A shares are expected to decrease from 109,382,000 to approximately 6,836,375, and Class B shares from 7,668,000 to approximately 479,250.
After the consolidation, the related share capital increase would raise authorized share capital from US$50,000 to US$800,000, comprising 400,000,000 authorized Class A shares and 100,000,000 authorized Class B shares. The increase creates authorized but unissued shares and does not itself increase outstanding shares. The consolidation is intended to support efforts to regain compliance with Nasdaq’s US$1.00 minimum bid price requirement; Nasdaq granted iTonic until October 19, 2026 to regain compliance, and the company said there is no assurance it will do so.
iTonic Holdings Ltd reported revenue of $100,906 for the six months ended June 30, 2026, compared with $67,507 for the six months ended June 30, 2025. Gross profit was $64,710 and gross margin was 64.13%, versus 79.03%. Net loss widened to $6,782,691 from $2,037,496; operating expenses were $5,146,444, including $977,841 of goodwill impairment and $718,258 of intangible-asset impairment.
Operating activities used $729,098 in cash, and cash and cash equivalents were $779,367 at June 30, 2026. The company said its net loss and negative operating cash flows raise substantial doubt about its ability to continue as a going concern; it may cease operations if it cannot secure additional short-term capital. A completed PIPE issued 100,000,000 Class A ordinary shares at US$0.20 each for US$20,000,000 in gross proceeds, with a six-month lock-up. It also paid US$20,000,000 in fully refundable advances for potential acquisitions that remained subject to due diligence and negotiation, with no definitive agreement.
Nasdaq extended the deadline to regain the US$1.00 minimum bid price requirement to October 19, 2026; failure may lead to delisting. Shareholders approved a 1-for-16 consolidation expected to take effect October 6, 2026, intended to help regain compliance.
iTonic Holdings Ltd (ITOC) reports that shareholders, at a September 9, 2026 extraordinary general meeting, approved a 1-for-16 Share Consolidation of both Class A and Class B Ordinary Shares, effective October 6, 2026, subject to Nasdaq notification and Nasdaq not objecting.
The consolidation will change the authorized share capital from 400,000,000 Class A and 100,000,000 Class B shares of par value US$0.0001 each to 25,000,000 Class A and 6,250,000 Class B shares of par value US$0.0016 each, with fractional shares rounded up. Immediately afterward, shareholders approved a Share Capital Increase back to 400,000,000 Class A and 100,000,000 Class B shares at the higher par value, and adopted a Fourth Amended and Restated Memorandum and Articles of Association reflecting these changes and updating certain governance provisions.
iTonic Holdings Ltd (symbol ITOC) announced that on August 27, 2026, Chief Financial Officer Zhixin Li resigned effective immediately. Ms. Li confirmed her resignation was not due to any disagreement with the company, its management or board, and that she has no claims against the company or its stakeholders.
On the same date, the board appointed Simin Tan as Chief Financial Officer. The company entered into an employment agreement and an indemnification agreement with Ms. Tan, filed as Exhibits 10.1 and 10.2. The company states there are no related-party transactions involving Ms. Tan requiring disclosure under Item 7.B of Form 20-F. Ms. Tan, age 31, has prior audit and tax experience with MarcumAsia CPAs LLP, PwC China, DAHUA CPA Firm, and Pattillo, Brown & Hill, LLP, and holds bachelor’s and master’s degrees from Baylor University. The contents of this report are incorporated by reference into iTonic’s existing Form S-8 and Form F-3 registration statements.
iTonic Holdings Ltd (ITOC) has called an extraordinary general meeting on September 9, 2026 (Hong Kong time), to be held virtually, for shareholders of record at the close of business on August 19, 2026.
Shareholders will vote on a 1-for-16 Share Consolidation of both Class A and Class B ordinary shares, effective 12:01 a.m. Eastern Time on October 6, 2026, subject to timely Nasdaq notification and Nasdaq not objecting. Fractional shares will not be issued and will instead be rounded up to the next whole share. Following the consolidation, an ordinary resolution would increase authorised share capital from US$50,000 to US$800,000, by creating additional Class A and Class B shares at the higher par value. A special resolution would adopt a Fourth Amended and Restated Memorandum and Articles of Association to reflect these changes and update provisions on share consolidation, quorum (at least one-third of voting rights) and notice. A further resolution would revoke prior share-consolidation authority granted on December 19, 2025.
iTonic Holdings Ltd reported a board change, with independent director Bin Wu resigning effective June 18, 2026, for personal reasons and without any disagreement over operations, policies, or practices. On the same date, Kun Yang was appointed as a new independent director and joined the Audit, Corporate Governance and Nominating, and Compensation Committees, becoming chair of the Corporate Governance and Nominating Committee. The company notes that Kun Yang meets Nasdaq and SEC independence requirements and has entered into a director agreement and an indemnification agreement with the company.
iTonic Holdings Ltd completed a new private share sale to bring in fresh capital. After mutually terminating a prior March 2026 subscription agreement, the company entered into new Subscription Agreements on April 16, 2026 for a private placement of 100,000,000 Class A ordinary shares at US$0.20 per share, for aggregate gross proceeds of approximately US$20,000,000.
The April 2026 private placement closed the same day, and iTonic issued 100,000,000 Class A ordinary shares to participating investors. These new shares are subject to a six-month lock-up period from the date of issuance, limiting immediate resale. The report also states that its contents are incorporated by reference into the company’s existing Form S-8 and Form F-3 registration statements.
iTonic Holdings Ltd received a 180-day extension from Nasdaq, until October 19, 2026, to regain compliance with Nasdaq’s minimum closing bid price requirement under Listing Rule 5550(a)(2). The company previously exhausted an initial 180-day compliance period that ended on April 20, 2026.
If iTonic does not meet the minimum bid price rule by the new deadline, Nasdaq may delist its Class A ordinary shares. iTonic could then request a review of any delisting determination by a Nasdaq Hearings Panel. The company continues to describe itself as a healthcare solution provider focused on brachytherapy treatment planning systems.